AUTL — Autolus Therapeutics
Median target
$5.8
calls from the last 12 months
Implied return
+202.1%
median target vs. price
Coverage
2 analysts · 3 calls
updated in the last 12 months
Consensus
2/0/0+2 net
Buy / Hold / Sell
Which analysts are behind AUTL's consensus?
See every current rating, price target and the analysts' track records for Autolus Therapeutics — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 2 analysts with calls on AUTL updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
AUTL elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-02 | Insiders | Piccina CintiaU.S. CCO & Country Gen M | Insider sale | 6.7K sh @ $2.34 | $16K |
More: insider activity · executive branch · trending